Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.023 |
0.047 |
? - ? |
Imipenem |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.06 |
0.12 |
? - ? |
Clindamycin (Cleocin) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.06 - >8 |
Clindamycin (Cleocin) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
0.12 - 0.25 |
Quinupristin/Dalfopristin (Synercid) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.5 |
0.12 - 1 |
Minocycline (Minocycline hydrochloride, Minocin) |
476 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
2 |
≤0.03 - >4 |
Gatifloxacin (Tequin) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
4 |
0.06 - >4 |
Levofloxacin (Levaquin, Quixin) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
12 |
≤0.06 - 0.25 |
Clindamycin (Cleocin) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.25 |
0.25 - >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.5 |
? - ? |
Quinupristin/Dalfopristin (Synercid) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.5 |
? - ? |
Tigecycline (GAR-936, Tigacyl) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
1 |
0.12 - 1 |
Tigecycline (GAR-936, Tigacyl) |
476 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>2 |
0.06 - >2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
2 |
0.12 - 64 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
476 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>2 |
? - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>8 |
? - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 - >8 |
Imipenem |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
1 |
≤0.5 - 1 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
1 |
≤0.5 - 8 |
Zosyn |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
2 |
≤0.12 - 8 |
Cefepime (Maxipime) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.5 |
>2 |
≤0.5 - >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
2 |
? - ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
4 |
0.25 - >128 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
476 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
1 |
0.5 - 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
1 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
≤0.12 - 4 |
Vancomycin (Vancocyn, Lyphocin) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
0.25 - 2 |
LBM415 (NVP-PDF-713, VIC-10495) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
265 |